Ignite Creation Date:
2025-12-24 @ 2:54 PM
Ignite Modification Date:
2025-12-25 @ 1:19 PM
Study NCT ID:
NCT06886659
Status:
COMPLETED
Last Update Posted:
2025-07-22
First Post:
2025-01-12
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study to Compare PK, Immunogenicity and Safety of Trastuzumab of Incepta Pharmaceuticals Ltd With Trastuzumab (Roche)
Sponsor:
Incepta Pharmaceuticals Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-23
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-28
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-28
Completion Date Type:
ACTUAL
First Submit Date:
2025-01-12
First Submit QC Date:
None
Study First Post Date:
2025-03-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-20
Last Update Post Date:
2025-07-22
Last Update Post Date Type:
ACTUAL